Mobile Trading

GLOBAL HEALTH LTD.

NSE : MEDANTABSE : 543654ISIN CODE : INE474Q01031Industry : Hospital & Healthcare ServicesHouse : Private
BSE1159.05-4.7 (-0.4 %)
PREV CLOSE ( ) 1163.75
OPEN PRICE ( ) 1170.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11655
TODAY'S LOW / HIGH ( )1151.20 1173.80
52 WK LOW / HIGH ( )995.05 1455.85
Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Operational & Financial Ratios
   Earnings Per Share (Rs)17.9217.8112.167.755.81
   CEPS(Rs)25.1324.2417.7512.876.13
   DPS(Rs)0.500.000.000.000.00
   Book NAV/Share(Rs)126.07108.0590.3563.60265.70
   Tax Rate(%)25.6423.7727.4230.0711.27
Margin Ratios
   Core EBITDA Margin(%)23.3024.7023.4821.1413.61
   EBIT Margin(%)19.5421.7119.7716.937.27
   Pre Tax Margin(%)17.5319.1516.5812.952.24
   PAT Margin (%)13.0414.6012.039.051.99
   Cash Profit Margin (%)18.2819.8717.5715.0410.51
Performance Ratios
   ROA(%)10.7211.478.465.850.99
   ROE(%)15.3117.9616.1713.402.23
   ROCE(%)20.5021.5618.7116.385.26
   Asset Turnover(x)0.820.790.700.650.50
   Sales/Fixed Asset(x)1.091.091.020.940.67
   Working Capital/Sales(x)4.043.682.695.5314.84
Efficiency Ratios
   Fixed Capital/Sales(x)0.910.920.981.071.49
   Receivable days25.0722.8225.2126.4335.67
   Inventory Days6.627.097.667.849.87
   Payable days79.1791.6897.6091.04139.29
Valuation Parameters
   PER(x)66.8574.3343.280.000.00
   PCE(x)47.6754.6129.650.000.00
   Price/Book(x)9.5012.255.820.000.00
   Yield(%)0.040.000.00
   EV/Net Sales(x)8.5010.625.050.170.30
   EV/Core EBITDA(x)32.5239.3719.950.761.92
   EV/EBIT(x)43.5048.9325.531.034.16
   EV/CE(x)8.4510.464.180.100.14
   M Cap / Sales8.7210.855.210.000.00
Growth Ratio
   Net Sales Growth(%)12.7420.8625.0349.81-3.58
   Core EBITDA Growth(%)9.2428.8938.05117.50-3.04
   EBIT Growth(%)1.5132.7245.99249.06-12.72
   PAT Growth(%)0.6846.6166.20581.08-20.70
   EPS Growth(%)0.6546.4856.9233.37-21.09
Financial Stability Ratios
   Total Debt/Equity(x)0.100.140.350.520.48
   Current Ratio(x)2.482.442.761.941.24
   Quick Ratio(x)2.372.332.651.811.14
   Interest Cover(x)9.718.486.204.251.45
   Total Debt/Mcap(x)0.010.010.06

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.